Best evidence on B-domain deletion and the immunogenicity of recombinant factor VIII

被引：11

作者：

Aledort, L. M. ^{[1
]}

Navickis, R. J. ^{[2
]}

Wilkes, M. M. ^{[2
]}

机构：

[1] Mt Sinai Sch Med, New York, NY 10029 USA

[2] Hygeia Associates, Grass Valley, CA USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷 / 11期

关键词：

PREVIOUSLY TREATED PATIENTS; PLASMA/ALBUMIN-FREE METHOD; HEMOPHILIA-A PATIENTS; CLINICAL-EVALUATION; POSTMARKETING SURVEILLANCE; FULL-LENGTH; SAFETY SURVEILLANCE; REGRESSION-ANALYSIS; HOME THERAPY; EFFICACY;

D O I：

10.1111/j.1538-7836.2011.04496.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2325 / 2327

页数：3

共 37 条

[1]

Abshire TC, 2000, THROMB HAEMOSTASIS, V83, P811

[2] Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies [J].

Aledort, L. M. ;

Navickis, R. J. ;

Wilkes, M. M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) :2180-2192

[3]

Auerswald G, 2009, J THROMB HAEMOST, V7, P524

[4]

AygorenPursun E, 1997, THROMB HAEMOSTASIS, V78, P1352

[5] Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients [J].

Blanchette, V. S. ;

Shapiro, A. D. ;

Liesner, R. J. ;

Navarro, F. Hernandez ;

Warrier, I. ;

Schroth, P. C. ;

Spotts, G. ;

Ewenstein, B. M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) :1319-1326

[6] Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study [J].

Collins, P. ;

Faradji, A. ;

Morfini, M. ;

Enriquez, M. M. ;

Schwartz, L. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) :83-89

[7]

Courter SG, 2001, SEMIN HEMATOL, V38, P44, DOI 10.1053/shem.2001.25893

[8] An observational study of sucrose-formulated recombinant factor VIII for Japanese patients with haemophilia A [J].

Delumeau, Jean-Christophe ;

Ikegawa, Chiho ;

Yokoyama, Chisato ;

Haupt, Verena .

THROMBOSIS AND HAEMOSTASIS, 2008, 100 (01) :32-37

[9] Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment [J].

Den Uijl, I. ;

Mauser-Bunschoten, E. P. ;

Roosendaal, G. ;

Schutgens, R. ;

Fischer, K. .

HAEMOPHILIA, 2009, 15 (06) :1215-1218

[10]

Fukutake K, 2009, J THROMB HAEMOST, V7, P823

← 1 2 3 4 →